Summary

Global Early Toxicity Testing Market is valued at approximately USD 1.21 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 8.53% over the forecast period 2024-2032. Early toxicity testing is a critical phase in the drug development process, aimed at assessing the potential adverse effects of new compounds or substances on living organisms. This preliminary evaluation helps identify safety concerns and informs subsequent research and development efforts. By conducting early toxicity testing, researchers can mitigate risks and optimize the safety profile of pharmaceutical candidates before advancing them to further stages of development. The Global Early Toxicity Testing Market shows promising growth due to the heightened emphasis of developing countries on R&D and increased investments in innovative drug and technology development for life-threatening diseases.

The increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders has heightened the demand for new and efficacious treatments, necessitating extensive toxicological testing to ensure their safety driving the growth of the Global Early Toxicity Testing Market. This surge in demand for early toxicity testing services is further propelled by the rising need for food processing and safety assurance, driven by consumer awareness and regulatory scrutiny. However, the high costs associated with early toxicity testing, particularly for comprehensive studies involving diverse organisms and multiple endpoints, pose a significant barrier, particularly for smaller companies with limited financial resources. Moreover, stringent regulatory requirements set by agencies such as the US FDA and the European Medicines Agency lengthen the approval process for new drugs, potentially impeding Global Early Toxicity Testing Market growth due to delayed market entry.

The key regions considered for the Global Early Toxicity Testing market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, Asia Pacific was the largest regional market. The Asia-Pacific region is poised to lead the Early Toxicity Testing (ETT) industry, driven by its robust focus on Research and Development (R&D) activities and the expanding sector in nations such as Japan, South Korea, and Australia. Furthermore, the increasing incidence of strokes in specific countries within the Asia-Pacific region, including China, India, Japan, and South Korea, is fueling growth in the ETT industry. Stroke represents a critical area of concern for early toxicity testing, as it plays a pivotal role in the development of new drugs and therapies for stroke patients. According to the National Center for Biotechnology Information, as of March 2022, there were 34 million incident cases of stroke, 17.8 million prevalent cases, and 2.3 million deaths from stroke among the Chinese population aged 40 years and older. Whereas, North America is accounted as the fastest growing region over the forecast period of 2024-2032.

Major market player included in this report are:
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
Bruker Corporation
Charles River Laboratories International Inc.
Danaher Corporation
Enzo Biochem Inc.
Eurofins Scientific SE
Evotec A.G.
Merck KGaA
PerkinElmer Inc.

The detailed segments and sub-segment of the market are explained below:

By Technique
In Vivo
In Vitro
In Silico

By Toxicity Endpoint
Genotoxicity
Dermal Toxicity
Skin Toxicity
Ocular Toxicity
Phototoxicity
Others

By End Use
Pharmaceutical Industry
Cosmetic Industry
Chemical Industry
Food Industry
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Chapter 1. Global Early Toxicity Testing Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. Global Early Toxicity Testing Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Technique
2.3.2. By Toxicity Endpoint
2.3.3. By End User
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Global Early Toxicity Testing Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Global Early Toxicity Testing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Early Toxicity Testing Market Size & Forecasts by Technique 2022-2032
5.1. In Vivo
5.2. In Vitro
5.3. In Silico
Chapter 6. Global Early Toxicity Testing Market Size & Forecasts by Toxicity Endpoint 2022-2032
6.1. Genotoxicity
6.2. Dermal Toxicity
6.3. Skin Toxicity
6.4. Ocular Toxicity
6.5. Phototoxicity
6.6. Others
Chapter 7. Global Early Toxicity Testing Market Size & Forecasts by End Use 2022-2032
7.1. Pharmaceutical Industry
7.2. Cosmetic Industry
7.3. Chemical Industry
7.4. Food Industry
7.5. Others
Chapter 8. Global Early Toxicity Testing Market Size & Forecasts by Region 2022-2032
8.1. North America Early Toxicity Testing Market
8.1.1. U.S. Early Toxicity Testing Market
8.1.1.1. Technique breakdown size & forecasts, 2022-2032
8.1.1.2. Toxicity Endpoint breakdown size & forecasts, 2022-2032
8.1.1.3. End Use breakdown size & forecasts, 2022-2032
8.1.2. Canada Early Toxicity Testing Market
8.2. Europe Early Toxicity Testing Market
8.2.1. U.K. Early Toxicity Testing Market
8.2.2. Germany Early Toxicity Testing Market
8.2.3. France Early Toxicity Testing Market
8.2.4. Spain Early Toxicity Testing Market
8.2.5. Italy Early Toxicity Testing Market
8.2.6. Rest of Europe Early Toxicity Testing Market
8.3. Asia-Pacific Early Toxicity Testing Market
8.3.1. China Early Toxicity Testing Market
8.3.2. India Early Toxicity Testing Market
8.3.3. Japan Early Toxicity Testing Market
8.3.4. Australia Early Toxicity Testing Market
8.3.5. South Korea Early Toxicity Testing Market
8.3.6. Rest of Asia Pacific Early Toxicity Testing Market
8.4. Latin America Early Toxicity Testing Market
8.4.1. Brazil Early Toxicity Testing Market
8.4.2. Mexico Early Toxicity Testing Market
8.4.3. Rest of Latin America Early Toxicity Testing Market
8.5. Middle East & Africa Early Toxicity Testing Market
8.5.1. Saudi Arabia Early Toxicity Testing Market
8.5.2. South Africa Early Toxicity Testing Market
8.5.3. Rest of Middle East & Africa Early Toxicity Testing Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Agilent Technologies Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Bio-Rad Laboratories Inc.
9.3.3. Bruker Corporation
9.3.4. Charles River Laboratories International Inc.
9.3.5. Danaher Corporation
9.3.6. Enzo Biochem Inc.
9.3.7. Eurofins Scientific SE
9.3.8. Evotec A.G.
9.3.9. Merck KGaA
9.3.10. PerkinElmer Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes